European researchers have developed an injectable hydrogel that could help repair and prevent further heart muscle damage after a heart attack. The therapeutic effect of multiple injections of this hydrogel into the cardiac tissue was assessed during the first preclinical study of its kind, demonstrating its efficacy for cardiac tissue remodeling following a heart attack, […]
Featured
Virta Health touts study of treatment preventing progression to Type 2 diabetes
Virta Health announced today that a study of its diabetes progression prevention treatment proved more effective than initially expected. Peer-reviewed research in Nutrients highlighted the fact that only 3% of trial participants progressed to Type 2 diabetes, while over half achieved prediabetes reversal during the first two years, according to a news release. Get the full story at […]
FDA grants breakthrough nod to Anuncia’s cerebral spinal fluid treatment
Anuncia announced today that it received FDA breakthrough device designation for its ReFlow system for cerebral spinal fluid (CSF) management. Lowell, Mass.-based Anuncia’s ReFlow Mini is intended to treat CSF disorders requiring shunting, including hydrocephalus, according to a news release. It has been optimized to serve a broad hydrocephalus population, including infants with non-communicating hydrocephalus, […]
Varian CEO Dow Wilson to retire after merger with Siemens Healthineers
Varian (NYSE: VAR) announced today that CEO Dow Wilson will retire after Siemens Healthineers‘ planned $16.4 billion acquisition of the company, which is expected to close in the first half of this year. Wilson, who has been with Varian for 16 years, will serve as a special advisor to Siemens Healthineers (Frankfurt: SHL) to help […]
Medtronic touts results of cardiac resynchronization therapy trial
Medtronic (NYSE:MDT) announced today that a study showed longer lives for patients treated with cardiac resynchronization therapy (CRT). Fridley, Minn.-based Medtronic’s Reverse (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) clinical trial for those with mild heart failure (HF) found that patients whose HF stabilizes with CRT live longer, similar to those whose condition improves […]
Ambu single-use endoscope wins Frost & Sullivan innovation award
Frost & Sullivan today announced that it awarded Ambu with a 2021 Global New Product Innovation Award. Ambu received the award for its single-use flexible endoscopes that are designed to make the devices safe, affordable and accessible. It has aView and aBox all-in-one video displays that eliminate the traditional video endoscopy tower size and expense to be […]
Abbott researchers help discover a clue to an HIV cure
Abbott announced today that a team including its scientists has uncovered a rare group of Democratic Republic of Congo residents who are HIV positive but have almost nonexistent viral loads without using antiretroviral treatments. This group of “HIV elite controllers” opens up a new area for researchers to discover biological trends that could inform the […]
Q BioMed wins federal contract for bone cancer drug
Q BioMed (OTCQB:QBIO) announced today that it signed an agreement for its Strontium89 drug to be included on the Federal Supply Schedule (FSS). New York-based Q BioMed’s agreement with the U.S. government provides U.S. veterans and other federal government agencies and eligible patients access to Strontium89, a treatment for metastatic bone pain related to common cancers, […]
Report: Biden to announce partnership for Merck to make J&J’s COVID-19 vaccine
President Joe Biden is reportedly set to announce a partnership in which Merck (NYSE:MRK) will make Johnson & Johnson’s (NYSE:JNJ) recently approved COVID-19 vaccine. The Washington Post reported that the agreement between the two competitors will boost the supply of the single-dose vaccine from J&J’s Janssen subsidiary, which received FDA emergency use authorization last week. Get the full story at […]
FDA accepts New Drug Application for Eyenovia pupil dilation tech
Eyenovia (NSDQ:EYEN) announced today that the FDA accepted its New Drug Aplication for its MydCombi pupil dilation agent. MydCombi is a fixed-combination mydriatic agent for potential use in comprehensive eye exams with a formulation for touchless fixed-combination microdosing in an effort to improve the patient experience, according to a news release. Get the full story at […]
Axonics, Micro Systems Technologies partners to make rechargeable SNM device
Axonics (NSDQ:AXNX) announced today that it entered into a strategic alliance with Micro Systems Technologies. Micro Systems Technologies (MST) manufactures printed circuit board assemblies for the Axonics r-SNM (sacral neuromodulation) system in Lake Oswego, Oregon, according to a news release. The newly minted strategic alliance expands the relationship between the two as the companies collaborate […]
